Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12P - Fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture › C12P 21 - Preparation of peptides or proteins
Patents for C12P 21 - Preparation of peptides or proteins (112,499)
08/2010
08/18/2010CN101809161A Method of producing heterogeneous protein
08/18/2010CN101809151A Method for cellulase production
08/18/2010CN101809033A Antibody having inhibitory activity on infection with hepatitis c virus (HCV), and use thereof
08/18/2010CN101809029A Peptide capable of extending half-life of peptide of interest in plasma
08/18/2010CN101805776A Method for preparing antler collagen
08/18/2010CN101805775A Method for preparing collagen from deer sinew
08/18/2010CN101805774A Method for comprehensively extracting oat polypeptide and oat glucan
08/18/2010CN101805773A Method for producing egg membrane protein
08/18/2010CN101805772A Method for extracting protein from excess sludge
08/17/2010US7777018 CDR-grafted anti-tissue factor antibodies and methods of use thereof
08/17/2010US7777017 The antibodies bind to whole bacteria and enhance phagocytosis and killing of the bacteria in vitro and enhance protection from lethal infection in vivo
08/17/2010US7777010 Recovering preferential protein from library; obtain genetically engineered cells, transform with vector coding preferential protein, express protein, isolate protein
08/17/2010US7777009 for modulation of chemokines; antiinflammatory agents; cancer
08/17/2010US7777008 ILT3 binding molecules and uses therefor
08/17/2010US7776620 Hapten-carrier conjugates for treating and preventing nicotine addiction
08/17/2010US7776598 Methods and compositions for polypeptide engineering
08/17/2010US7776579 detoxifying a pathogenic prion protein by bringing a surface which may be contaminated with a pathogenic prion protein into contact with an enzyme exhibiting an activity of digesting a protein highly resistant to denaturation and degradation
08/17/2010US7776577 drug screening; used to identify compounds that act as agonists and antagonists and modulate the expression of the novel PGP synthase
08/17/2010US7776575 improved substrate specificity to glucose, amino acid sequence having the substitution, deletion, insertion or addition of one or more amino acid residues excluding amino acid 365 in the amino acid sequence; glucose sensors, glucose assay kits
08/17/2010US7776574 Thrombolytic enzyme and a process for its preparation
08/17/2010US7776565 converting N-acetylmannosamine (ManNAc) and phosphoenol pyruvate (PEP) to sialic acid (SA) in a cell by enhancing expression of sialic acid synthetase (SAS) in the cell; for expressing sialylated glycoproteins in insects
08/17/2010US7776552 Drug screening; for inhibiting apoptosis in mammalian cells; zinc finger domains; consensus sequences; genetic engineering; for treating AIDS, alzheimer's disease, parkinson's disease, amyotrophic lateral sclerosis (ALS), retinitis pigmentosa, autoimmune diseases
08/17/2010US7776523 assaying a sample comprising prostate cells, an RNA comprising a Gag or Pol encoding sequence of a human endogenous mouse mammary tumor virus (MMTV)-like subgroup 2 (HML-2) retrovirus, HERV-K (CH)
08/17/2010US7776340 has a low level of homology to the enteric canine coronavirus, but which has a high level of homology to all bovine coronavirus strains (eg Quebec and LY138) and human coronavirus strain OC43
08/17/2010US7776336 Compositions comprising Yersinia pestis antigens
08/17/2010US7776335 Microorganismal enzymatic polypeptide for use in developing vaccine for prevention and treatment of nesserial infection
08/17/2010US7776330 Carcinoembryonic antigen (CEA); utilizes crystallographic structural data to select immunoglobulin framework having maximum structural overlap non-human donor molecule
08/17/2010US7776311 D-amino acid peptides
08/17/2010US7775469 treatment of conditions characterized by a need to modulate migratory-cell movement associated with specific sites in a subject; isolating a stromal-cell-derived fugetactic agent
08/17/2010CA2506580C Assay kit and antibody for human low molecular weight cd14
08/17/2010CA2368797C Cell culture process
08/17/2010CA2314396C High expression escherichia coli expression vector
08/17/2010CA2271955C Poxvirus-based expression vectors containing heterologous inserts derived from lentiviruses
08/17/2010CA2269634C Reagents and methods useful for detecting diseases of the breast
08/17/2010CA2203679C Oral immunization with transgenic plants
08/12/2010WO2010090079A1 Monoclonal antibody reacting specifically with stromelysin 1
08/12/2010WO2010090040A1 Monoclonal antibodies that recognize cholangiocarcinoma-specific sugar chain epitopes
08/12/2010WO2010089120A1 Novel method for the manufacturing of neurotoxins
08/12/2010WO2010062399A3 Csf1r extracellular domain fusion molecules and treatments using same
08/12/2010US20100205690 Plants With Increased Yield
08/12/2010US20100205683 Method for enabling stable expression of transgene
08/12/2010US20100205680 Mammary gland- specific human erytheropoietin expression vector, transgenic animal and method for producing human erythropoietin using same
08/12/2010US20100205678 Oocyte spindle-associated factors improve somatic cell cloning
08/12/2010US20100204444 Multifunctional protein simultaneously delivering antibodies and nanoparticles
08/12/2010US20100204128 Novel peptides
08/12/2010US20100204104 Fusion proteins containing two tgf-beta binding domains of tgf-beta type ii receptor
08/12/2010US20100204098 Peptides with antifungal activity
08/12/2010US20100204091 SIVA Ubiquitination and/or Degradation-Related Activity and Modulators Thereof
08/12/2010US20100204080 Novel Cellulases and Their Uses
08/12/2010US20100203592 Method for production of glutathione or gamma-glutamylcysteine
08/12/2010US20100203591 Bioreactor, in particular for NMR spectroscopy
08/12/2010US20100203590 Antibodies that bind interleukin-4 receptor
08/12/2010US20100203589 Method for obtaining active beta-ngf
08/12/2010US20100203588 Polypeptides for inducing a protective immune response against staphylococcus aureus
08/12/2010US20100203587 Use of dna gyrase inhibitors for in vitro polypeptide synthesis reactions
08/12/2010US20100203586 Modified 13-hydroperoxide lyases and uses thereof
08/12/2010US20100203585 Calcium-Binding Photoprotein, Gene Encoding the Same, and Use Thereof
08/12/2010US20100203584 Host Cells Used For Production of Recombinant Protein
08/12/2010US20100203583 Alteration and modulation of protein activity by varying post-translational modification
08/12/2010US20100203582 Protein Expression System Involving Mutated Severe Respiratory Syndrome-Associated Coronavirus 3C-Like Protease
08/12/2010US20100203509 Inducible fluorescently-tagged protein expression system
08/12/2010US20100203135 Skin Equivalent Culture
08/12/2010US20100203073 Hsv-1 epitopes and methods for using same
08/12/2010US20100203063 Pestivirus species
08/12/2010US20100203057 Novel compounds
08/12/2010US20100203056 Anti-pd-l1 antibodies and their use to enhance t-cell function
08/12/2010US20100203050 Erythropoietin fusion protein
08/12/2010US20100203049 Interleukin-10 Antibodies
08/12/2010US20100203046 Fc gamma receptor-binding polypeptide variants and methods related thereto
08/12/2010US20100203042 Recombinant anti-vla4 antibody molecules
08/12/2010US20100203041 Antibodies to egfl7 and methods for their use
08/12/2010US20100203029 Lysyl oxidase-like 1 (loxl1) and elastogenesis
08/12/2010US20100202972 Use of gene variants of the human meis1, btbd9, map2k5, lbxcor1, ptprd or a2bp1 gene for diagnostic and therapeutic approaches to restless legs syndrome (rls)
08/12/2010US20100202968 Method of Providing Disease-Specific Binding Molecules and Targets
08/12/2010US20100202962 Cripto blocking antibodies and uses thereof
08/11/2010EP2216414A1 Cell-free translation system
08/11/2010EP2216403A2 Esterases and related nucleic acids and methods
08/11/2010EP2216400A1 Method for manufacturing an active component of a medicine or diagnosis agent in MDCJ cell suspension culture
08/11/2010EP2216343A1 Human monoclonal antibody against a costimulatory signal transduction molecule AILIM and pharmaceutical use thereof
08/11/2010EP2216046A2 Anti-glypican 3 antibody
08/11/2010EP2215252A2 Rationally-designed meganucleases with recognition sequences found in dnase hypersensitive regions of the human genome
08/11/2010EP1581660B1 Method of detecting dna single strand breaks
08/11/2010CN101802211A Anti-RANTES antibodies and methods of use thereof
08/11/2010CN101802210A Transgenic mammals that produce exogenous proteins in milk
08/11/2010CN101802198A immunogenic polypeptides and monoclonal antibodies
08/11/2010CN101802192A Method for production of antibody
08/11/2010CN101802005A Compositions and methods comprising binding proteins for adalimumab
08/11/2010CN101801994A Preparation of Romidepsin
08/11/2010CN101801209A whey protein hydrolysate
08/11/2010CN101799476A Reagent box for sieving autoantibody for tsh receptor
08/11/2010CN101798587A Method for separating and purifying corn anti-hypertensive peptides
08/11/2010CN101798586A Process for producing aminated complex-type sugar chain derivatives
08/11/2010CN101798576A Encoding sequence for Late Embryogenesis Abundant protein of Jatropha curcas and application in plants
08/10/2010US7772465 Bacillus thuringiensis gene with lepidopteran activity
08/10/2010US7772459 genetically engineered to produce non-natural components in their saliva to modify its composition; include phytase, an antibody, a growth hormone, a blood protein, serum albumin, fibrinogen, prothrombin, thrombin and von Willebrand Factor
08/10/2010US7772386 immunization against Mycobacterium tuberculosis; purified nucleic acid molecule coding for oxidoreductase from M. tuberculosis; production of a vaccine against a virulent strain of M. tuberculosis
08/10/2010US7772372 Neoplasm specific antibodies and uses thereof
08/10/2010US7772365 secreted tumor necrosis factor receptor polypeptides; modulates B cell activation; inhibiting ztnf4 activity
08/10/2010US7771972 Nucleotide sequences coding vessicant toxic amide and modular polyketide synthase for use in identifying modulator for prevention and treatment of cell proliferative disorders
08/10/2010US7771971 Using trangenic fungus to produce heterologous proteins; culturing
1 ... 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 ... 1125